Immunological aspects of prophylactic UVB and PUVA therapy in polymorphic light eruption

Extraction of chlorophyll a from Tetradesmus obliquus-a method upgrade.

Biologia futura·2024

The beneficial effect of plasmapheresis in mixed connective tissue disease with coexisting antiphospholipid syndrome.

Lupus·2014

Derailed B cell homeostasis in patients with mixed connective tissue disease.

Human immunology·2013

Distinct phenotypes in mixed connective tissue disease: subgroups and survival.

Lupus·2012

[An experimental model of transgastric ooforectomy using a porcine model].

Chirurgia (Bucharest, Romania : 1990)·2010

Clinical and immunoserological characteristics of the transition from primary to overlap antiphospholipid syndrome.

Lupus·2010

Phototherapy for neonatal hyperbilirubinemia.

Photo-dermatology·1989

Cis-urocanic acid stereospecifically modulates human monocyte IL-1 production and surface HLA-DR antigen expression, T-cell IL-2 production and CD4/CD8 ratio.

Photo-dermatology·1989

Local increase in interleukin-1-like activity following UVB irradiation of human skin in vivo.

Photo-dermatology·1989

Photocarcinogenesis is retarded by a partly photodegraded solution of para-aminobenzoic acid.

Photo-dermatology·1989

Effect of ultraviolet B on nonimmunologic contact reactions induced by dimethyl sulphoxide, phenol and sodium lauryl sulphate.

Photo-dermatology·1989

Effect of ultraviolet radiation on Ia expression by keratinocytes.

Photo-dermatology·1989

Blinatumomab administration in the outpatient setting: Safety and health care utilization.

Cancer·2026

Subcutaneous versus intravenous ultra-low dose rituximab in rheumatoid arthritis: a randomised controlled PK-PD non-inferiority trial.

Rheumatology (Oxford, England)·2026

The Role of γδ T Cells in Ischemic Stroke: Insights From the Perspective of the Brain-Gut Axis.

CNS neuroscience & therapeutics·2026

Macrophage migration inhibitory factor promotes immune evasion in multiple myeloma through myeloid-derived suppressor cell immunosuppression and major histocompatibility complex class I downregulation: implications for targeted therapy.

Haematologica·2026

Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications.

Haematologica·2026

Brentuximab vedotin as consolidation treatment in patients with stage I/II Hodgkin's lymphoma and FDG-PET positivity after 2 cycles of ABVD: final analysis of the BRAPP2 trial.

Haematologica·2026

Related Experiment Videos

Immunological aspects of prophylactic UVB and PUVA therapy in polymorphic light eruption

Related Concept Videos

Extraction of chlorophyll a from Tetradesmus obliquus-a method upgrade.

The beneficial effect of plasmapheresis in mixed connective tissue disease with coexisting antiphospholipid syndrome.

Derailed B cell homeostasis in patients with mixed connective tissue disease.

Distinct phenotypes in mixed connective tissue disease: subgroups and survival.

[An experimental model of transgastric ooforectomy using a porcine model].

Clinical and immunoserological characteristics of the transition from primary to overlap antiphospholipid syndrome.

Phototherapy for neonatal hyperbilirubinemia.

Cis-urocanic acid stereospecifically modulates human monocyte IL-1 production and surface HLA-DR antigen expression, T-cell IL-2 production and CD4/CD8 ratio.

Local increase in interleukin-1-like activity following UVB irradiation of human skin in vivo.

Photocarcinogenesis is retarded by a partly photodegraded solution of para-aminobenzoic acid.

Effect of ultraviolet B on nonimmunologic contact reactions induced by dimethyl sulphoxide, phenol and sodium lauryl sulphate.

Effect of ultraviolet radiation on Ia expression by keratinocytes.

Blinatumomab administration in the outpatient setting: Safety and health care utilization.

Subcutaneous versus intravenous ultra-low dose rituximab in rheumatoid arthritis: a randomised controlled PK-PD non-inferiority trial.

The Role of γδ T Cells in Ischemic Stroke: Insights From the Perspective of the Brain-Gut Axis.

Macrophage migration inhibitory factor promotes immune evasion in multiple myeloma through myeloid-derived suppressor cell immunosuppression and major histocompatibility complex class I downregulation: implications for targeted therapy.

Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications.

Brentuximab vedotin as consolidation treatment in patients with stage I/II Hodgkin's lymphoma and FDG-PET positivity after 2 cycles of ABVD: final analysis of the BRAPP2 trial.

Related Experiment Videos

Immunological aspects of prophylactic UVB and PUVA therapy in polymorphic light eruption

Related Concept Videos

Related Articles